Hydroxytyrosol from olive fruits prevents blue-light-induced damage in human keratinocytes and fibroblasts
You can also read about Kyowa Hakko's broader innovations in our SupplySide Global 2025 recap, which covers both Setria developments and updates on Cognizin citicoline research
The injectable obesity medications Semaglutide 2.4 mg, a selective GLP-1 receptor agonist, produces robust and durable weight loss of approximately 1516% over 68 weeks ( Tirzepatide, a dual gastric inhibitory polypeptide (GIP)/GLP-1 receptor agonist, delivers even greater weight loss, exceeding 20% at the highest dose in pivotal trials ( Retatrutide, a triple agonist targeting GIP, GLP-1, and glucagon receptors, represents a further step in efficacy, with 24.2% weight loss achieved within 48 weeks in phase 2 studies ( Survodutide, an oxyntomodulin analogue, achieved clinically meaningful weight loss ( Table 2
CoQ 10 function and role in heart failure and ischemic heart disease
Trends Mol Med 2015
Taking L-carnitine by mouth seems to improve exercise tolerance in people with chest pain